Stockscreener 앱 받기
518.43
0.03%
-0.02
전일 마감가:
$518.41
열려 있는:
$518.5
하루 거래량:
591.45K
Relative Volume:
0.33
시가총액:
$195.58B
수익:
$42.88B
순이익/손실:
$6.34B
주가수익비율:
31.36
EPS:
16.53
순현금흐름:
$7.27B
1주 성능:
+1.84%
1개월 성능:
-3.64%
6개월 성능:
-15.55%
1년 성능:
-10.65%
1일 변동 폭
$513.06
$520.64
1주일 범위
$508.71
$525.72
52주 변동 폭
$493.30
$627.88
써모 피셔 사이언티픽 Stock (TMO) Company Profile
명칭
Thermo Fisher Scientific Inc
전화
(781) 622-1000
주소
168 THIRD AVENUE, WALTHAM, MA
TMO을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TMO
Thermo Fisher Scientific Inc
|
518.32 | 195.58B | 42.88B | 6.34B | 7.27B | 16.53 |
|
DHR
Danaher Corp
|
210.78 | 150.27B | 23.88B | 3.90B | 5.30B | 5.28 |
|
A
Agilent Technologies Inc
|
120.93 | 34.86B | 6.53B | 1.26B | 1.31B | 4.35 |
|
IDXX
Idexx Laboratories Inc
|
422.29 | 34.33B | 3.90B | 887.87M | 798.08M | 10.67 |
|
IQV
Iqvia Holdings Inc
|
184.96 | 32.96B | 15.41B | 1.37B | 2.11B | 7.50 |
써모 피셔 사이언티픽 Stock (TMO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-01-10 | 업그레이드 | Bernstein | Mkt Perform → Outperform |
| 2024-12-23 | 개시 | Scotiabank | Sector Perform |
| 2024-10-14 | 개시 | Redburn Atlantic | Buy |
| 2024-10-01 | 개시 | Stephens | Overweight |
| 2024-08-28 | 개시 | Wells Fargo | Overweight |
| 2024-06-03 | 재개 | Jefferies | Buy |
| 2024-03-18 | 재개 | Citigroup | Neutral |
| 2024-01-24 | 다운그레이드 | Barclays | Overweight → Equal Weight |
| 2024-01-08 | 다운그레이드 | Bernstein | Outperform → Mkt Perform |
| 2023-12-18 | 개시 | HSBC Securities | Buy |
| 2023-12-13 | 개시 | Wolfe Research | Outperform |
| 2023-10-26 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-10-25 | 업그레이드 | Wells Fargo | Underweight → Equal Weight |
| 2023-09-28 | 개시 | Bernstein | Outperform |
| 2023-09-06 | 재개 | Citigroup | Buy |
| 2023-07-19 | 개시 | Raymond James | Outperform |
| 2023-07-19 | 재확인 | Robert W. Baird | Outperform |
| 2023-07-13 | 업그레이드 | Credit Suisse | Neutral → Outperform |
| 2023-04-04 | 재확인 | Barclays | Overweight |
| 2022-12-14 | 개시 | Deutsche Bank | Buy |
| 2022-12-07 | 개시 | RBC Capital Mkts | Outperform |
| 2022-10-27 | 다운그레이드 | The Benchmark Company | Buy → Hold |
| 2022-08-25 | 개시 | Credit Suisse | Neutral |
| 2022-04-25 | 다운그레이드 | Wells Fargo | Equal Weight → Underweight |
| 2022-01-26 | 재개 | Barclays | Overweight |
| 2021-10-20 | 업그레이드 | Citigroup | Neutral → Buy |
| 2021-10-15 | 재개 | Cowen | Outperform |
| 2021-08-05 | 재개 | Credit Suisse | Outperform |
| 2021-07-16 | 개시 | The Benchmark Company | Buy |
| 2021-03-18 | 업그레이드 | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-03-03 | 개시 | Barclays | Overweight |
| 2021-01-08 | 업그레이드 | Credit Suisse | Neutral → Outperform |
| 2020-12-16 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2020-12-02 | 개시 | Goldman | Buy |
| 2020-11-10 | 개시 | KeyBanc Capital Markets | Sector Weight |
| 2020-09-30 | 개시 | Atlantic Equities | Overweight |
| 2020-09-14 | 개시 | Morgan Stanley | Overweight |
| 2020-08-20 | 재개 | JP Morgan | Overweight |
| 2020-07-15 | 업그레이드 | Cleveland Research | Neutral → Buy |
| 2020-07-07 | 재확인 | Needham | Buy |
| 2020-04-23 | 재확인 | Needham | Buy |
| 2020-01-31 | 재확인 | Needham | Buy |
| 2020-01-22 | 개시 | Credit Suisse | Neutral |
| 2020-01-08 | 개시 | Wells Fargo | Equal Weight |
| 2020-01-07 | 개시 | Citigroup | Buy |
| 2019-11-15 | 개시 | Stifel | Buy |
| 2019-07-25 | 재확인 | Needham | Buy |
| 2019-07-16 | 다운그레이드 | Needham | Strong Buy → Buy |
| 2019-05-30 | 개시 | Wolfe Research | Outperform |
| 2019-05-23 | 재확인 | Needham | Strong Buy |
| 2019-04-22 | 재확인 | Needham | Strong Buy |
| 2019-04-16 | 재확인 | BofA/Merrill | Buy |
모두보기
써모 피셔 사이언티픽 주식(TMO)의 최신 뉴스
Genetic Toxicology Testing Market Is Booming Worldwide | Thermo - openPR
Life Science Instrumentation Market Demand, Growth and Future - openPR
Thermo Fisher Scientific (TMO) Fell as Expectations for Demand Recovery in 2025 Continue to Moderate - Insider Monkey
GMP Cell Therapy Consumables Market Deep Research 2025-2032 | - openPR
South East Asia And South Asia Industrial Microbiology Market - openPR
Proteinase K Market Future Business Opportunities 2025-2032 | Thermo Fisher Scientific Inc., Merck KGaA, Qiagen N.V. - openPR
$100 Invested In This Stock 20 Years Ago Would Be Worth This Much Today - Benzinga
Thermo Fisher Scientific Thrives Amid Diabetes Market Expansion - Zenopa
Thermo Fisher Scientific Introduces the Vulcan™ Automated Lab to Transform Semiconductor Analysis - MSN
Bioreactors Market to Witness Remarkable Growth with Thermo Fisher Scientific, Inc., Merck KGaA - openPR
Pharmacogenomics Market Growth and Future Scope 2025-2032 | - openPR
Thermo Fisher Scientific's $4B Filtration Acquisition & - openPR
The Zacks Analyst Blog Highlights Visa, Johnson & Johnson, Thermo Fisher and AMREP - TradingView
DNA Sequencing Market Detailed In New Research Report 2025 | - openPR
Top Stock Reports for Visa, Johnson & Johnson & Thermo Fisher Scientific - MSN
Thermo Fisher Scientific (TMO): One of the Best Diabetes Stocks to Buy According to Billionaires - Insider Monkey
Thermo Fisher Scientific (NYSE:TMO) Advances Semiconductor Manufacturing With New Automated Lab Solution - Yahoo Finance
Biomedical Refrigerators Market to Witness Remarkable Growth with Thermo Fisher Scientific, Aegis Scientific, Inc. - openPR
Helicobacter Pylori Diagnostic Market Top Companies Study - openPR
Is Thermo Fisher Scientific Inc. (TMO) the Best Strong Buy Stock to Buy Right Now? - Insider Monkey
Biotechnology Reagents and Kits Market A Comprehensive Study - openPR
Gas Chromatography Market Is Booming Worldwide 2025-2032 | - openPR
Thermo Fisher Scientific debuts Transcend VTLX-1 UHPLC system for automated sample preparation - R&D World
$100 Invested In Thermo Fisher Scientific 20 Years Ago Would Be Worth This Much Today - Benzinga
Is the Market Bullish or Bearish on Thermo Fisher Scientific? - Benzinga
Senior VP & General Counsel Michael Boxer Sold A Bunch Of Shares In Thermo Fisher Scientific - Simply Wall St
HSBC Adjusts Price Target on Thermo Fisher Scientific to $670 From $700, Keeps Buy Rating - Marketscreener.com
Layoff Tracker: GRO Biosciences Cuts Staff Amid Quest for Strategic Alternatives - BioSpace
Faces of HR: Thermo Fisher Scientific's Pallavi Srivastava on the importance of fungibility of skills within the workforce - Human Resources Online
New exhibit at Discovery Center showcases lab techniques for kids - MyStateline.com
Market Whales and Their Recent Bets on TMO Options - Benzinga
CRDMO Market Research 2025: A Highly Competitive $328 - GlobeNewswire
Exosomes Drug Market Detailed In New Research Report 2025 | Thermo Fisher Scientific, Inc., Bio-Techne - openPR
Thermo Fisher Scientific’s CHF1.425 Billion Bond Issuance - Global Legal Chronicle
Laboratory Equipment and Disposables Market is expected - openPR
Complement C4 Antibody Market Research 2025: Growing Focus on Precision Medicine and Targeted Therapies, and Increasing Investment in Immunotherapies and Biologic Drugs - GlobeNewswire Inc.
Ex-Dividend Reminder: Gilead Sciences, CONMED and Thermo Fisher Scientific - Nasdaq
Gas Chromatograph Market Industry Report 2025, with Profiles of Agilent, Shimadzu, Thermo Fisher Scientific, PerkinElmer, Shandong Huifen, Shanghai Kechuang, Zhejiang Fuli Analytical Instrument & BFRL - GlobeNewswire Inc.
Thermo Fisher Executive Cashes In on Stock Sale! - TipRanks
Thermo Fisher Scientific SVP sells $2.01 million in stock By Investing.com - Investing.com Australia
Thermo Fisher Scientific SVP sells $2.01 million in stock - Investing.com
Neurological Biomarkers: Global Market Review 2020-2024 and - GlobeNewswire
Neurological Biomarkers: Global Market Review 2020-2024 and Forecast to 2030, Featuring Analysis of PerkinElmer, Abbott Labs, Thermo Fisher Scientific, Banyan Biomarkers, Bio-Rad Labs & More - Yahoo Finance
Molecular Breeding Market Insights, Competitive Intelligence and Growth Forecast 2025-2030 - GlobeNewswire Inc.
Mexico In-Vitro Diagnostics Market Deep Research 2025-2032 | Thermo Fisher Scientific Inc., Siemens Healthineers - openPR
Thermo Fisher Scientific: Not Living Up To Its Positioning (NYSE:TMO) - Seeking Alpha
WilmerHale Advises Thermo Fisher on its CHF 1.425 Billion Offering of Bonds - WilmerHale
Cas Nuclease Market Size, Forecast 2031 by Key Companies- Thermo - openPR
Thermo Fisher Scientific Inc. to Host Earnings Call - ACCESS Newswire
Insider Selling: Thermo Fisher Scientific Inc. (NYSE:TMO) CEO Sells $5,166,700.00 in Stock - Defense World
A New Era of STEMOptimization for Advanced Materials Discovery - AZoM
써모 피셔 사이언티픽 (TMO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.21%
자본화:
|
볼륨(24시간):